CELL AND GENE THERAPY INSIGHTS

Volume 2 Issue 1

Cell and Gene Therapy Insights Volume 2 Issue 1

Download PDF

Featuring

Issue Spotlight: The Cell & Gene Therapy Manufacturing Pathway: Part 1
Other articles

The Cell & Gene Therapy Manufacturing Pathway: Part 1

Peter Zandstra

Guest Editor:

Peter Zandstra, Professor & Director, School of Biomedical Engineering at University of British Columbia

Foreword

Spotlight on the cell & gene therapy manufacturing pathway

Spotlight on the cell & gene therapy manufacturing pathway

Chris Mason, Elisa Manzotti

Expert Insight

Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Centralized or decentralized manufacturing? Key business model considerations for cell therapies

Nicholas Medcalf

Cell and gene therapy manufacturing: the necessity for a cost-based development approach

Cell and gene therapy manufacturing: the necessity for a cost-based development approach

S Callens, J Hasan, R McCoy et al.

Drivers and methodologies for making cell therapy process changes

Drivers and methodologies for making cell therapy process changes

Gregory Russotti

Evolving product attributes through the lens of MSC translation

Evolving product attributes through the lens of MSC translation

Perspective

Key considerations in optimizing pluripotent stem cell bioprocessing

Key considerations in optimizing pluripotent stem cell bioprocessing

Toward a scalable and consistent manufacturing process for the production of human MSCs

Toward a scalable and consistent manufacturing process for the production of human MSCs

Innovator Insight

Translational cell & gene therapy collaborations: accelerating time to market

Translational cell & gene therapy collaborations: accelerating time to market

Journal articles

Interview

Dr James Shapiro: the hype, hope & reality of cell therapy for diabetes

Dr James Shapiro: the hype, hope & reality of cell therapy for diabetes